Brief: Cancer Genetics Q1 Loss Per Share $0.56 From Continuing Operations

Vyant Bio

24/06/2020 22:45

June 24 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * Q1 LOSS PER SHARE $0.56 FROM CONTINUING OPERATIONS
    * Q1 REVENUE $1.4 MILLION VERSUS $1.8 MILLION
    * CANCER GENETICS - CASH, CASH EQUIVALENTS ABOUT $3.9
MILLION AS
OF MARCH 31, 2020, WITH RESTRICTED CASH

Source text for Eikon: https://bit.ly/3fW3a3b
Further company coverage:  CGIX.O 

 ((Briefs@thomsonreuters.com;))